Otsuka Pharmaceutical Co., Ltd. (Otsuka Seiyaku) is a corporation located at 2-9 Kanda Tsukacho, Chiyoda-ku, Tokyo, where CEO and CEO Inoue Makoto was established on August 10, 1964 (corporate number: 7010001012986). The final registration was updated on October 5, 2015, and a new establishment (corporate number registration) was carried out. Trademarks such as neuacto, ONSTEXA, and Strobio are registered. White company information is currently being posted.
The financial results for the fiscal year ending December 2024 (revenue: 650.914 billion yen, net income: 130.975 billion yen) . Employees and former employees rated the review site on various job change meetings with a score of 3.4/5.0 and Kaisha's reputation of 68/100.
There is no legal violation/disposition/black information posted.
Company Profile
| Corporate number | 7010001012986 |
|---|---|
| Corporate name | Otsuka Pharmaceutical Co., Ltd. |
| Furigana | Great skeleton |
| Business overview | 36 years old, manufacturing and selling pharmaceuticals, nutritional foods, etc. |
| Address/Map | 〒101-0048 2-9 Kanda Tsukacho, Chiyoda-ku, Tokyo |
| President/Representative | Representative Director Inoue Makoto |
| URL | https://www.otsuka.co.jp/ |
| telephone number | Phone number: 03-6717-1400 Fax number: 03-6717-1499 |
| Establishment | August 10, 1964 |
| Industry | manufacturing industry |
| Corporate number designation date | 2015/10/05 |
| Last registration update date | 2015/10/05 |
Press releases and advertisements from Otsuka Pharmaceutical Co., Ltd.
Financial history of Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.'s financial results for the December 61st period (61st period) were 650.914 billion yen in sales and 130.975 billion yen in final profit. This was revealed in an "electronic announcement" published on the "Otsuka Pharmaceutical Co., Ltd. official website" on February 20, 2025.
List of past financial results for Otsuka Pharmaceutical Co., Ltd.
| Closing date | document | Sales | net profit | retained earnings | total assets |
|---|---|---|---|---|---|
| December 31, 2024 | 61st term | 650.914 billion yen | 130.975 billion yen | 902.268 billion yen | 1.514.681 billion yen |
| December 31, 2023 | 60th term | 716.54 billion yen | 186.62 billion yen | 867.452 billion yen | 1.413.299 billion yen |
| December 31, 2022 | 59th term | 597.093 billion yen | 124.254 billion yen | 742.966 billion yen | 1,357,919 billion yen |
| December 31, 2021 | 58th term | 522.542 million yen | 84.773 billion yen | 661.047 billion yen | 1,352,126 billion yen |
| December 31, 2020 | 57th term | 554.757 billion yen | 114.693 billion yen | 668.545 billion yen | 1,353.271 million yen |
![Medicinal hair growth agent [hair tonic glow gel]](https://companydata.tsujigawa.com/wp-content/uploads/2024/07/hair-tonic-glow-gel-pr-01-150x150.jpg)
